NCT02789592View on ClinicalTrials.gov

Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
REM Sleep Behavior DisorderParkinson Disease
Interventions
DRUG

Melatonin PR

For experimental treatment of RBD

DRUG

Clonazepam

For experimental treatment of RBD

DRUG

Melatonin PR placebo

Placebo pill manufactured to mask melatonin PR 2mg tablet

DRUG

Clonazepam placebo

Placebo pill manufactured to mask clonazepam 0.5mg tablet

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT02789592 - Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease | Biotech Hunter | Biotech Hunter